MiniMed Group, Inc. MMED

 — 
19.98 (0.46) (2.25%) as of 25 Sep
Market cap
$5.8B
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jul '26 Jan '26 Jul '25 Apr '25 Older periods
Revenue
843.00 790.00 723.00 —

+2 more quarters

Cost of Revenue
378.00 428.00 314.00 —
Gross Profit
465.00 362.00 409.00 —
R&D Expenses
115.00 114.00 125.00 —
SG&A Expenses
312.00 309.00 283.00 —
Operating Income
4.00 (100.00) (14.00) —
EBT
4.00 (99.00) (13.00) —
Income Tax Provision
4.00 12.00 3.00 —
Income after Tax
— (111.00) (16.00) —
Non-Controlling Interest
0.00 8.00 3.00 —
Net Income Common
0.00 (119.00) (19.00) —
EPS (Basic)
0.00 (0.44) (0.06) —
EPS (Diluted)
0.00 (0.44) (0.06) —
Shares (Basic, Weighted)
281.00 252.81 252.80 —
Shares (Diluted, Weighted)
281.00 252.81 252.80 —
Gross Margin
55.16% 45.82% 56.57% —
EBIT Margin
0.47% (12.66%) (1.94%) —
EBT margin
0.47% (12.53%) (1.80%) —
Net Profit Margin
0.00% (15.06%) (2.63%) —
EBITDA
45.00 (100.00) 25.00 —
EBIT
4.00 (100.00) (14.00) —
Income from Continuous Operations
— (111.00) (16.00) —
Consolidated Net Income/Loss
0.00 (111.00) (16.00) —
EPS (Basic, from Continuous Ops)
— (0.44) (0.06) —
EPS (Diluted, from Cont. Ops)
— (0.44) (0.06) —
EPS (Basic, Consolidated)
— (0.44) (0.06) —
EPS (Diluted, Consolidated)
— (0.44) (0.06) —
Shares (Diluted, Average)
281.00 — — —
EBITDA Margin
5.34% (12.66%) 3.46% —
Operating Cash Flow Margin
(5.81%) (3.42%) (19.50%) 0.00%

Fold the line items

In millions of $ except per-share values · columns are period end dates